CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,470,130 | -25.5% | 1,139,636 | -0.7% | 0.00% | – |
| Q2 2023 | $1,974,243 | +16.3% | 1,147,816 | +2.1% | 0.00% | – |
| Q1 2023 | $1,696,896 | -18.4% | 1,123,772 | -13.6% | 0.00% | – |
| Q4 2022 | $2,080,002 | -20.3% | 1,300,001 | -27.8% | 0.00% | – |
| Q3 2022 | $2,609,000 | -22.0% | 1,799,363 | -1.5% | 0.00% | – |
| Q2 2022 | $3,343,000 | -74.9% | 1,826,591 | -63.4% | 0.00% | – |
| Q1 2022 | $13,328,000 | -38.0% | 4,992,094 | +0.6% | 0.00% | -100.0% |
| Q4 2021 | $21,488,000 | -16.4% | 4,962,362 | -1.8% | 0.00% | 0.0% |
| Q3 2021 | $25,718,000 | -20.0% | 5,052,601 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $32,160,000 | -19.8% | 5,080,623 | -2.1% | 0.00% | 0.0% |
| Q1 2021 | $40,109,000 | +60.9% | 5,188,705 | +36.4% | 0.00% | 0.0% |
| Q4 2020 | $24,924,000 | -8.7% | 3,805,179 | -7.3% | 0.00% | 0.0% |
| Q3 2020 | $27,310,000 | -20.8% | 4,106,727 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $34,464,000 | +14.0% | 4,137,309 | +5.0% | 0.00% | 0.0% |
| Q1 2020 | $30,225,000 | -9.4% | 3,940,778 | -1.9% | 0.00% | 0.0% |
| Q4 2019 | $33,372,000 | +12.6% | 4,016,048 | -0.0% | 0.00% | 0.0% |
| Q3 2019 | $29,649,000 | -32.1% | 4,017,583 | +3.3% | 0.00% | -50.0% |
| Q2 2019 | $43,647,000 | +5.1% | 3,890,049 | +0.7% | 0.00% | 0.0% |
| Q1 2019 | $41,542,000 | -28.7% | 3,864,391 | +0.1% | 0.00% | -33.3% |
| Q4 2018 | $58,298,000 | -18.5% | 3,860,928 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $71,570,000 | -3.0% | 3,868,566 | +19.9% | 0.00% | 0.0% |
| Q2 2018 | $73,755,000 | +3.3% | 3,226,401 | +28.5% | 0.00% | 0.0% |
| Q1 2018 | $71,418,000 | +27.8% | 2,510,305 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $55,870,000 | +49.3% | 2,646,599 | +28.5% | 0.00% | +50.0% |
| Q3 2017 | $37,430,000 | +33.2% | 2,059,901 | +13.6% | 0.00% | +100.0% |
| Q2 2017 | $28,093,000 | +60.8% | 1,812,512 | +79.1% | 0.00% | 0.0% |
| Q1 2017 | $17,476,000 | +16386.8% | 1,011,984 | +10405.4% | 0.00% | – |
| Q4 2016 | $106,000 | -27.4% | 9,633 | +3.1% | 0.00% | – |
| Q3 2016 | $146,000 | +89.6% | 9,344 | +23.2% | 0.00% | – |
| Q2 2016 | $77,000 | +7600.0% | 7,585 | +7055.7% | 0.00% | – |
| Q1 2016 | $1,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |